Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lactamase beta-like 1 (LACTBL1) is a protein-coding gene in humans, annotated based on sequence similarity to beta-lactamase enzymes. Its protein product is predicted to be located in the membrane, and its closest paralog is the LACTB gene. At present, there is no confirmed biological function or enzymatic activity for LACTBL1. It does not have established roles in signal transduction, cell cycle, immune function, or any common pharmacological processes. No drugs, biomarkers, or clinical utility are linked to this gene, and its relevance to human disease remains poorly defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lactamase beta-like 1 (LACTBL1).